Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Proteomics and mathematical modeling of longitudinal CSF differentiates fast versus slow ALS progression

Annals of Clinical and Translational Neurology(2023)10.1002/acn3.51890Source: DataRank Database

Proteomics and mathematical modeling of longitudinal CSF differentiates fast versus slow ALS progression is a research paper published in Annals of Clinical and Translational Neurology (2023). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

Linked data & code

pxd doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 3.76)OA: goldTopics (70)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Krystine Garcia‐Mansfield,Antonio Pompeiano ORCID,Jiyan An,Victoria David‐Dirgo,Ritin Sharma ORCID

Live enrichment

PubMed:37646115 PMC:PMC10647001 OpenAlex:https://openalex.org/W4386272217

National Cancer Institute

Grant: CA033572

National Institute of Neurological Disorders and Stroke

Grant: NS061867

NINDS NIH HHS

Grant: R01 NS061867

NINDS NIH HHS

Grant: R56 NS061867

NCI NIH HHS

Grant: P30 CA033572

National Institutes of Health

Grant: 5R01NS061867-06

Peptide and Protein Biomarkers for Amyotrophic Lateral Sclerosis (ALS)

National Institutes of Health

Grant: 5P30CA033572-27

Developmental Funds

Barrow Neurological Foundation

FWCI

3.76

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1002/acn3.51890

publisherhttps://doi.org/10.1002/acn3.51890

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51890

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37646115

repositoryhttps://onlinelibrary.wiley.com/doi/full/10.1002/acn3.51890

Fields of Study

Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatmentsGenetic Neurodegenerative Diseases0303 health sciences03 medical and health sciences

MeSH Terms

Amyotrophic Lateral SclerosisHumansBiomarkersDisease ProgressionProteomeProteomicsRetinol-Binding Proteins, Plasma

Keywords

ProteomeProteomicsMedicineQuantitative proteomicsAmyotrophic lateral sclerosisBiomarkerDiseaseBioinformaticsComputational biologyOncologyInternal medicineBiologyBiochemistryDisease Progression (mesh)Medical Biochemistry and MetabolomicsNeurodegenerativeClinical and health psychologyPlasmaBrain Disorders (rcdc)1103 Clinical Sciences (for)2.1 Biological and endogenous factors32 Biomedical and Clinical Sciences (for-2020)Neurosciences (rcdc)Research ArticlesNeurodegenerative (rcdc)Humans (mesh)Proteomics (mesh)3209 Neurosciences (for-2020)Biomarkers (mesh)Neurological5203 Clinical and health psychology (for-2020)Disease ProgressionRC321-571ALS (rcdc)Clinical Sciences610Neurosciences. Biological psychiatry. NeuropsychiatryRare Diseases (rcdc)Rare DiseasesHumansProteome (mesh)RC346-429Biomedical and Clinical SciencesNeurological (hrcs-hc)4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac)Neurosciences2.1 Biological and endogenous factors (hrcs-rac)3205 Medical Biochemistry and Metabolomics (for-2020)1109 Neurosciences (for)Brain Disorders4.1 Discovery and preclinical testing of markers and technologiesAmyotrophic Lateral Sclerosis (mesh)Retinol-Binding ProteinsNeurology. Diseases of the nervous systemALSRetinol-Binding Proteins, PlasmaBiomarkersPlasma (mesh)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being